Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

HER2-low Breast Cancer × eribulin × 30 days × Clear all

Sponsor

Conditions

Breast Neoplasms 5 Triple Negative Breast Neoplasms 4 Urinary Bladder Neoplasms 2 Urethral Neoplasms 1 Ureteral Neoplasms 1 Carcinoma, Transitional Cell 1

Interventions

disitamab vedotin 1 RC48 antibody 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡